If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRc365 Holding Regulatory News (RCGH)

Share Price Information for Rc365 Holding (RCGH)

Share Price is delayed by 15 minutes
Get Live Data
2.60    -0.05 (-1.89%)
Bid:
2.50
Ask:
2.70
Spread: 0.20 (8.00%)
Market Cap: £4.60m
RCGH Live PriceLast checked at - London Stock Exchange

Intraday Rc365 Holding Share Chart

Entry into £3m Convertible Loan Note Instrument

26 Feb 2026 11:09

RNS Number : 5625U
RC365 Holding PLC
26 February 2026
 

 

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED WHICH, BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, FORMS PART OF UK LAW. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ("RIS"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

RC365 Holding plc

("RC365", the "Company" or the "Group")

Entry into £3,000,000 Convertible Loan Note Instrument

 

RC365 Holding plc (LSE: RCGH), an established payment solutions and fintech company (the "Company"), announces that it has entered into a convertible loan note instrument (the "CLN Instrument") with VBG Consulting Holdings Limited (the "Lender"), constituting £3,000,000 unsecured convertible loan notes (the "Loan Notes").

The CLN Instrument has been executed by the Company as a deed poll. The Loan Notes have not yet been issued.

Conditionality and Funding Commitment

The Lender's obligation to subscribe for the Loan Notes is subject to a condition precedent, being approval by the UK Financial Conduct Authority ("FCA") of a prospectus relating to the Loan Notes. Upon satisfaction of this condition, the Lender will be obligated to subscribe for the full £3,000,000 principal amount in accordance with the terms of the CLN Instrument.

Key Terms of the Convertible Loan Notes

The principal terms of the CLN Instrument are summarised below, as set out in the fully executed document:

The principal terms of the CLN Instrument are summarised below:

· Principal Amount

£3,000,000 unsecured convertible loan notes.

· Maturity

Three (3) years from the date of issuance of the Loan Notes.

· Interest and Fees

12% rolled-up coupon accruing from issuance, payable on maturity or conversion

6% facility fee payable in cash

6% warrants to the Lender on the same terms as the A share purchase warrants

Lender's legal fees and expenses

The facility fee, together with interest, is payable on maturity or conversion in accordance with the terms of the CLN Instrument.

· Conversion

The Lender may convert outstanding principal, together with accrued interest and, if elected, the facility fee, into ordinary shares of the Company at any time up to the Maturity Date, subject to necessary legal and regulatory approvals.

Conversion price: 1 penny per ordinary share

Each conversion share will be issued with:

§ one A share purchase warrant (exercise price equal to 100% of the conversion price, each with a six-month term), and

§ one B share purchase warrant (exercise price equal to 125% of the conversion price, each with a twelve-month term)

· Takeover Code Protection

Conversion is restricted such that no Noteholder (together with any persons acting in concert with it) may become interested in 30 per cent. or more of the Company's voting rights following conversion, unless (i) a waiver of the obligation to make a mandatory offer under Rule 9 of the Takeover Code has been granted by the Panel on Takeovers and Mergers and approved by independent shareholders, or (ii) such conversion would not give rise to an obligation to make a mandatory offer under Rule 9 of the Takeover Code.

· Security

The Loan Notes are unsecured.

· Use of Proceeds

The proceeds, if and when drawn, are expected to be used to support the Company's working capital requirements and corporate growth initiatives.

· Condition Precedent

The Lender's obligation to subscribe for the Loan Notes arises only upon FCA approval of the relevant prospectus. Prior to fulfilment of this condition precedent, the Loan Notes remain authorised but unissued.

Commentary

Chi Kit Law, Chief Executive Officer of RC365, commented:

"The execution of today's Convertible Loan Note Instrument represents a significant step forward in securing committed financing for RC365. Once the FCA approves the prospectus, the Company will be able to issue the Loan Notes and strengthen its balance sheet in support of our planned growth strategy. We appreciate the continued support from VBG Consulting Holdings Limited."

The Directors of the Company accept responsibility for the contents of this announcement. To the best of their knowledge, the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect its import.

-Ends-

 

Enquiries:

 

RC365 Holding plc

 

Chi Kit LAW, Chief Executive Officer

T: +852 3157 1393

E: ir@rc365plc.com

Bowsprit Partners Limited (Financial Adviser)

T: +44 (0) 203 833 4430

About RC365 Holding plc

 

RC365 Holding plc (LSE: RCGH) is an established payment solutions and fintech company. It operates primarily in East and Southeast Asia through its core subsidiaries of Regal Crown Technology and the recently acquired HC Capital

 

For over 10 years, the Company has delivered efficient and secure payment gateway solutions and IT support and development services for payment and financial systems, including ERP solutions. In 2021, it commenced providing digital remittance and payment services, which expanded to include foreign exchange and asset linked credit card solutions. These services are provided to multinational merchants, SMEs and individuals. RC365 intends to expand into the virtual banking market and geographically, including in the UK and wider Europe.

 

For more information, visit: https://www.rc365plc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CONFQLFLQLLBBBQ
12
Date   Source Headline
6th Jul 20267:00 amRNSLaunch of Wealth Management System
3rd Jul 20267:00 amRNSStrategic Partnership with Blacksilver Trust
17th Jun 20267:00 amRNSMerchant POS Agreement with StarCruises
10th Jun 20267:00 amRNSPlacing, Broker Appointment, Cancellation of CLN
8th Jun 20267:00 amRNSSoft Launch of RC3.0 Application
30th Mar 202612:39 pmRNSResult of General Meeting
6th Mar 202610:18 amRNSNotice of GM
26th Feb 202611:09 amRNSEntry into £3m Convertible Loan Note Instrument
5th Jan 20263:55 pmRNSStatement re Share Price Movement
18th Dec 202510:30 amRNSDirectorate change
11th Dec 202512:00 pmRNSHalf-year Financial Report
4th Sep 202511:23 amRNSResult of Annual General Meeting
11th Aug 20257:00 amRNSPosting of Annual Report and Notice of AGM
8th Aug 20257:00 amRNSClarification Statement
4th Aug 20257:00 amRNSAppointment of Financial Adviser
31st Jul 20254:54 pmRNSFinal Results and Publication of Annual Report
26th Feb 20256:00 pmRNSAppointment of auditors
6th Jan 20257:00 amRNSDirectorate Change
20th Dec 20247:00 amRNSChange of Adviser
18th Dec 20247:00 amRNSRepayment of Convertible Loan Amount
25th Nov 20247:01 amRNSInterim Results
25th Nov 20247:00 amRNSDivestiture of RCPAY HK
10th Sep 20241:28 pmRNSResult of Annual General Meeting
21st Aug 202412:00 pmRNSIssue of Equity
15th Aug 20247:00 amRNSDirectorate Change and Notice of AGM
30th Jul 20247:00 amRNSFinal Results and Publication of Annual Report
22nd Jul 20247:00 amRNSRC365 acquires Money Lenders Licence
26th Jun 20247:40 amRNSIssue of Equity
15th May 202410:20 amRNSIssue of Equity
23rd Apr 20248:16 amRNSIssue of Equity
18th Apr 20247:00 amRNSGovernment Grant
3rd Apr 202410:56 amRNSIssue of Equity
27th Mar 202412:00 pmRNSResult of GM
11th Mar 20247:00 amRNSNotice of General Meeting
11th Mar 20247:00 amRNSUpdate on YouneeqAI Agreement
4th Mar 20247:00 amRNSIssue of Convertible Loan Note
8th Feb 20247:00 amRNSAppointment of Auditor
31st Jan 20247:00 amRNSContract Win
22nd Dec 20237:00 amRNSInterim Report
14th Dec 20237:00 amRNSResignation of Auditor
4th Dec 20237:00 amRNSCo-Sponsor at the Hong Kong Economic Summit 2024
30th Oct 20237:00 amRNSMemorandum of Understanding with KOMAJU
28th Sep 20237:00 amRNSEstablishment of New Subsidiary in Malaysia
12th Sep 20233:31 pmRNSResult of AGM
1st Sep 20237:00 amRNSAgreement signed with YouneeqAI for IP Rights
14th Aug 20237:00 amRNSLOI with YouneeqAI for IP Rights
11th Aug 20237:00 amRNSNotice of AGM
3rd Aug 20237:00 amRNSNew Customer Win in Malaysia
26th Jul 20237:00 amRNSAnnual Financial Report
20th Jul 20237:00 amRNSmPOS Development Agreement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.